RSV Roundtable

Last year’s historic RSV season left many wondering if this was going to become a recurring trend. Physicians weigh in on what they are seeing at their institutions in terms of infection rates.

In the second installment of RSV Roundtable, our panel explains how they are educating patients and parents when it comes to RSV, vaccines and preventive measures, and limited treatment availability.

In the third installment of RSV Roundtable, our panel discusses the impact nirsevimab has had this RSV season.

In the fourth installment of RSV Roundtable, our panel explains the challenges in protecting the senior population against RSV.

The panel discusses the importance of discussing the immunizations with patients now, as well as the value of them in future seasons.